Cargando…

Genetics of Familial Non-Medullary Thyroid Carcinoma (FNMTC)

SIMPLE SUMMARY: Non-medullary thyroid carcinoma (NMTC) originates from thyroid follicular epithelial cells and is considered familial when occurs in two or more first-degree relatives of the patient, in the absence of predisposing environmental factors. Familial NMTC (FNMTC) cases show a high geneti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Diquigiovanni, Chiara, Bonora, Elena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125431/ https://www.ncbi.nlm.nih.gov/pubmed/33946592 http://dx.doi.org/10.3390/cancers13092178

Ejemplares similares

Co-Occurrence of Familial Non-Medullary Thyroid Cancer (FNMTC) and Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Associated Tumors—A Cohort Study
por: Aswath, Kshama, et al.
Publicado: (2021)

Whole Genome Sequencing Prioritizes CHEK2, EWSR1, and TIAM1 as Possible Predisposition Genes for Familial Non-Medullary Thyroid Cancer
por: Srivastava, Aayushi, et al.
Publicado: (2021)

Genetic Mutations and Variants in the Susceptibility of Familial Non-Medullary Thyroid Cancer
por: Miasaki, Fabíola Yukiko, et al.
Publicado: (2020)

Omics Technologies Improving Breast Cancer Research and Diagnostics
por: Orsini, Arianna, et al.
Publicado: (2023)

Editorial: Non-Syndromic Familial Non-Medullary Thyroid Carcinoma: Clinical and Genetic Update
por: Valerio, Laura, et al.
Publicado: (2022)

Genetic susceptibility to hereditary non-medullary thyroid cancer
por: Kamani, Tina, et al.
Publicado: (2022)

Familial non-medullary thyroid cancer: a critical review
por: Capezzone, M., et al.
Publicado: (2020)

Familial Cancer Variant Prioritization Pipeline version 2 (FCVPPv2) applied to a papillary thyroid cancer family
por: Kumar, Abhishek, et al.
Publicado: (2018)

A Germline Mutation in the POT1 Gene Is a Candidate for Familial Non-Medullary Thyroid Cancer
por: Srivastava, Aayushi, et al.
Publicado: (2020)

Hypercalcitoninemia is not Pathognomonic of Medullary Thyroid Carcinoma
por: Toledo, Sergio PA, et al.
Publicado: (2009)

Calcium and Reactive Oxygen Species Signaling Interplays in Cardiac Physiology and Pathologies
por: De Nicolo, Bianca, et al.
Publicado: (2023)

Genetic and Epigenetic of Medullary Thyroid Cancer
por: Khatami, Fatemeh, et al.
Publicado: (2018)

Thyroid: Medullary Carcinoma
por: Somnay, Yash R., et al.
Publicado: (2013)

Familial Non-Medullary Thyroid Carcinoma in Pediatric Age: Our Surgical Experience
por: Spinelli, Claudio, et al.
Publicado: (2021)

Three siblings with familial non-medullary thyroid carcinoma: a case series
por: Rashid, Muhammad Owais, et al.
Publicado: (2016)

Medullary Thyroid Carcinoma: An Update on Imaging
por: Kushchayev, Sergiy V., et al.
Publicado: (2019)

The Genetic Aspects of Medullary Thyroid Carcinoma: Recognition and Management
por: Williamson, Paula, et al.
Publicado: (1996)

Kinase inhibitors for advanced medullary thyroid carcinoma
por: Schlumberger, Martin, et al.
Publicado: (2012)

Management of medullary carcinoma of the thyroid: a review
por: Jayasinghe, Ravindri, et al.
Publicado: (2022)

BRAF Exon 15 Mutations in Papillary Carcinoma and Adjacent Thyroid Parenchyma: A Search for the Early Molecular Events Associated with Tumor Development
por: Acquaviva, Giorgia, et al.
Publicado: (2020)

Current Guidelines for Management of Medullary Thyroid Carcinoma
por: Kim, Mijin, et al.
Publicado: (2021)

PET Imaging in Recurrent Medullary Thyroid Carcinoma
por: Treglia, Giorgio, et al.
Publicado: (2012)

Cabozantinib for the Treatment of Metastatic Medullary Thyroid Carcinoma
por: Nix, Nancy M., et al.
Publicado: (2014)

Recent Updates on the Management of Medullary Thyroid Carcinoma
por: Kim, Bo Hyun, et al.
Publicado: (2016)

Medullary carcinoma of the thyroid gland.
por: Russell, C.
Publicado: (1980)

Medullary carcinoma of the thyroid: an update
por: Alevizaki, Maria
Publicado: (2013)

Pediatric Medullary Thyroid Carcinoma
por: Starenki, Dmytro, et al.
Publicado: (2015)

Whole Genome Sequencing of Familial Non-Medullary Thyroid Cancer Identifies Germline Alterations in MAPK/ERK and PI3K/AKT Signaling Pathways
por: Srivastava, Aayushi, et al.
Publicado: (2019)

Analysis of loss of heterozygsity effect on thyroid tumor with oxyphilia cell locus in familial non medullary thyroid carcinoma in Iranian families
por: Shirazi, Hasti Atashi, et al.
Publicado: (2012)

Clinical and Genetic Features of a Large Monocentric Series of Familial Non-Medullary Thyroid Cancers
por: Cirello, Valentina, et al.
Publicado: (2021)

Recent advances in the biology and therapy of medullary thyroid carcinoma
por: Nelkin, Barry
Publicado: (2017)

Diagnostic tests for medullary thyroid carcinoma: an umbrella review
por: Trimboli, Pierpaolo, et al.
Publicado: (2023)

Current Knowledge of Germline Genetic Risk Factors for the Development of Non-Medullary Thyroid Cancer
por: Hińcza, Kinga, et al.
Publicado: (2019)

RET mutations in a large indian family with medullary thyroid carcinoma
por: Mahesh, D. M., et al.
Publicado: (2014)

International Medullary Thyroid Carcinoma Grading System: A Validated Grading System for Medullary Thyroid Carcinoma
por: Xu, Bin, et al.
Publicado: (2022)

Genetic Predisposition to Familial Nonmedullary Thyroid Cancer: An Update of Molecular Findings and State-of-the-Art Studies
por: Bonora, Elena, et al.
Publicado: (2010)

Medullary Thyroid Carcinoma: Targeted Therapies and Future Directions
por: Pinchot, Scott N., et al.
Publicado: (2009)

Mixed Medullary-Follicular Carcinoma of the Thyroid
por: Tohidi, Maasumeh, et al.
Publicado: (2013)

Educational Case: Medullary Thyroid Carcinoma
por: McGary, Carl T.
Publicado: (2018)

Simultaneous medullary-papillary thyroid carcinoma
por: Al-Mashat, Faisal M. H.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_6qc9efq5pk1v3ge6vgpqab022g